International

Where are you?

To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.

USA
International

Media & Investors

Transparency is key at Kuros Biosciences. Explore essential information – from corporate documents to our current share price, all in one place.

Press releases

Here are our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.

14 Aug 2025

Adhoc Press Release

Kuros Biosciences Reports First Half of 2025 Results

05 Aug 2025

Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance

13 May 2025

Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich

15 Apr 2025

Annual General Meeting of Kuros Biosciences approves all resolutions

15 Apr 2025

Adhoc Press Release

Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025

11 Mar 2025

Adhoc Press Release

Kuros Biosciences grows sales to CHF 75.6 million for 2024

Investor calendar

Date Event
Oct 16, 2025

Trading Update Q3 2025

Mar 10, 2026

Earnings Release FY 2025

Apr 14, 2026

Annual Shareholders’ General Meeting 2026

Apr 14, 2026

Trading Update Q1 2026

Aug 13, 2026

Earnings Release HY1 2026

Oct 15, 2026

Trading Update Q3 2026

Reports, Corporate Governance & Meetings

Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.

Reports & Presentations

Corporate Governance

Shareholder Meetings

Regulatory filings

Information on disclosures under the Swiss Stock Exchange Act can be found on the website of the SIX Swiss Exchange website.

Management Transactions

Stabilization

Significant Shareholder Transactions

Analysts

For more information regarding analyst reports, please contact:

Laura Pfeifer-Rossi
Octavian AG
sales@octavian.ch
Tel: +41 44 520 1588

Christophe Dombu
Kepler Cheuvreux
cdombu@keplercheuvreux.com
Tel: +33 1 53 65 35 78

Thomas Meyer
Baader Bank AG
tmeyer@helvea.com
Tel: +41 43 388 9265

Investor Relations

For more information regarding investor
relations, please contact:

Alexandre Müller
Kuros Biosciences
Investor Relations
IR@kurosbio.com
Tel: +41 43 268 32 31

Want to receive our press releases?